arrow
N

Nobuyuki Yamamoto

Kobe University
H指数:15
被引数:830

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Distinct Clinical Significance of Minimal Residual Disease Detected by 7NB-mRNAs Expression in Bone Marrow at Different Time Points of High-Risk Neuroblastoma Patients

高危神经母细胞瘤患者不同时间点骨髓中由7NB-mRNAs表达检测到的微小残留病具有不同的临床意义。

Biology
IF3.5
2026-03-050
OAAI
Efficacy of pembrolizumab plus pemetrexed in older patients with non-squamous NSCLC according to PD-L1 expression status: Results from the CJLSG1901 study

帕博利珠单抗联合培美曲塞在PD-L1表达状态不同的老年非鳞状NSCLC患者中的疗效:CJLSG1901研究的结果

2026-01-010
OAAI
Intensity-Modulated Radiotherapy for Locally Advanced Lung Cancer in the Immunotherapy Era: A Prospective Study WJOG12019L

调强放射治疗在免疫治疗时代局部晚期肺癌中的应用:一项前瞻性研究 WJOG12019L

2025-06-010
OAAI
Longitudinal recurrence risk of adjuvant cytotoxic chemotherapy and gefitnib in resected lung cancer: A combined analysis of phase III studies

辅助细胞毒性化疗和吉非替尼在切除肺癌中的纵向复发风险:一项III期研究的联合分析

2025-03-010
OAAI
Final Analysis Data and Exploratory Biomarker Analysis of a Randomized Phase 2 Study of Osimertinib Plus Bevacizumab Versus Osimertinib Monotherapy for Untreated Patients With Nonsquamous NSCLC Harboring EGFR Mutations: The WJOG9717L Study
2024-11-011
OA
Germline and somatic RUNX1 variants in a pediatric bone marrow failure cohort
2023-02-201
OAAI
Reliability and Validity of the Japanese Pediatric Version of Memorial Symptom Assessment Scale

日本版儿科纪念症状评估量表的信度和效度

2022-05-014
OAAI
A case of autoimmune enteropathy with CTLA4 haploinsufficiency
2022-01-307
OAAI
Hematopoietic Cell Transplantation Rescues Inflammatory Bowel Disease and Dysbiosis of Gut Microbiota in XIAP Deficiency
2021-10-0116
PREAI
The emergence of CD20-/CD19-tumor cells after rituximab therapy for Epstein-Barr virus-associated post-transplant lymphoproliferative disorder complicated with hemophagocytic lymphohistiocytosis

利妥昔单抗治疗epstein-barr病毒相关的移植后淋巴增生性疾病并发噬血细胞性淋巴组织细胞增生症后CD20-/CD19-tumor细胞的出现

2013-10-305
PREAI